Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Matinas Biopharma Hl (MTNB)

2.77 +0.25 (+9.92%)

6/23/2017  4:00pm

Open:

2.50

Pre. Close:

2.52

High:

2.79

Low:

2.27

Volume:

4,626,954

Market Cap:

253.17M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-06-23 4:36:44 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 3.57     One year: 4.17

Support:

Support1: 2.42    Support2: 2.02

Resistance:

Resistance1: 3.06    Resistance2: 3.57

Pivot:

2.56

Moving Averages:

MA(5): 2.69     MA(20): 2.66

MA(100): 2.91     MA(250): 1.91

MACD:

MACD(12,26): -0.03     Signal(12,26,9): -0.05

%K %D:

%K(14,3): 67.24     %D(3): 65.45

RSI:

RSI(14): 52.85

52-Week:

High: 3.99  Low: 0.60  Change(%): 354.1

Average Vol(K):

3-Month: 990  10-Days 1180

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MTNB has closed below upper band by 19.9%. Bollinger Bands are 19.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Fri, 28 Apr 2017 21:43:48 GMT
BRIEF-Matinas Biopharma Holdings enters into controlled equity offering sales ...

Fri, 11 Nov 2016 20:54:57 GMT
Matinas BioPharma Registers Shares, Prepares For Critical Trials

Sat, 24 Jun 2017 00:54:46 GMT
Streetwise Analysis on Shares of Matinas BioPharma Holdings, Inc. (AMEX:MTNB)

Mon, 19 Jun 2017 12:33:45 GMT
Here's the Latest Chart Setup For Matinas BioPharma Holdings, Inc. (MTNB)

Fri, 23 Jun 2017 13:52:30 GMT
The Way Analysts See Cara Therapeutics, Inc. (CARA) And Matinas BioPharma ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

91.40

Shares Float (M)

72.30

% Held by Insiders

% Held by Institutions

Shares Short (K)

980

Shares Short Prior Month (K)

961

Stock Financials

EPS

-0.480

EPS Est. Current Year

-0.280

EPS Est. Next Year

-0.240

EPS Est. Next Quarter

-0.050

Forward EPS

-0.240

Book Value (p.s.)

0.140

PEG Ratio

Profit Margin

Operating Margin

-70190.86

Return on Assets (ttm)

-45.6

Return on Equity (ttm)

-85.4

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.114

Qtrly Earnings Growth

Operating Cash Flow (M)

-7.61

Levered Free Cash Flow (M)

-4.16

FoxReading.com

Valuation

P/E

-5.77

P/E Growth Ratio

0.10

P/BV

19.79

P/S

P/CF

-33.27

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.